Tubeless Insulin Pump Market Outlook:
Tubeless Insulin Pump Market size was over USD 2.4 billion in 2025 and is poised to exceed USD 16.69 billion by 2035, witnessing over 21.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of tubeless insulin pump is estimated at USD 2.86 billion.
The tubeless insulin market is driven by the rising incidence of type 1 diabetes across the globe. In 2022, a report published by the National Library of Medicine, the incidence of type 1 diabetes has drastically increased after the COVID-19 pandemic. Tubeless insulin pumps are cost-effective, user-friendly, and can be worn beneath any garment. As per a World Health Organization (WHO) report published in 2022, the world population is aging, and by 2050, 22% of the world population will be 60 years or above.
Manufacturers across the globe are focused on improving the accuracy and user-friendliness of tubeless insulin pumps to gain standard approvals for commercialization. For instance, the first automated tubeless insulin pump, Insulet’s Omnipod 5, received FDA approval in January 2022. Omnipod 5 is the first product that can be controlled via smartphone. Such ongoing groundbreaking innovations are expected to boost tubeless insulin pump market growth going ahead.
